Title: Co-Relation between CEA Level and Different Stages of Colorectal Carcinoma

Authors: Dr Arun Antony, Dr Annu Sajeev, Dr Gejoe.G

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i12.41

Abstract

Introduction: Colorectal carcinoma is the third most common cancer in men and second in women worldwide. Incidence rates per 100,000 in India for males is 4.3/100000 and for females is 3.4/100000. Levels of various substances in blood can help act as tumor marker for the detection, staging and prognosis of the patients.CEA levels are elevated in 60-90% of patients with colorectal carcinomas. Despite its lack of specificity it can help in making clinical decisions and assessing therapy response.

Aims

1 .To assess if preoperative CEA level an independant indicator of severity of colorectal cancer(as indicated by TNM staging)

  1. To find out percentage of cases showing elevation of CEA Levels in different stages of colorectal carcinoma

Materials and Methods: We conducted a study on all patients admitted in Department of surgery in Government medical college, Thiruvananthapuram over a period of 20 months with diagnosis of colorectal carcinoma who already had a baseline CEA levels done as a part of workup. Smokers were included in the study but were considered as having high CEA levels only when the level was more than 5ng/ml. Data was entered in structured proforma and correlated with CEA levels and statistically analysed using Chi square test and Mann whitney U test.

Results: Out Of 78 patients studied only 29(37%) had elevated CEA Levels irrespective of the stage of the disease. majority (56%) presented with bleeding per rectum. most common blood group affected was O+ve. CECT detected lesions in 95% cases. Most common histopathological pattern was well differentiated adenocarcinoma. On analysis using Mann Whitney U test it was found that CEA levels rose progressively with the stage of the disease but  p-value was found to be 0.066.

Conclusion: From this study it was found that colorectal carcinoma was predominantly a disease of people aged above 50 yrs of age, majority (56%) presented with bleeding per rectum as main symptom and inferred that there is no correlation between CEA levels and different stages of colorectal carcinoma. Hence CEA levels cannot be used to predict the severity of colorectal carcinoma as indicated by TNM Staging.

Keywords: Colorectal carcinoma, CEA (Carcinoembryonic antigen).

References

  1. Indian J Gastroenterol (Jan–Feb 2011) 30(1):3–6DOI 10.1007/s12664-010-0076-2- Colorectal cancer in India: controv-ersies, enigma and primary prevention -K. M. Mohandas
  2. Shinya H,Wolff WI. Morphology, anatomic distribution and cancer potential of colonic polyps.Ann.Surg.1979;190:679-683
  3. Woodhouse C: Guidelines for monitoring of patients with uretero sigmoidoscopy. Gut 51(Suppl V):v15, 2002.
  4. Jass JR, Young J, Leggett BA: Evolution of colorectal cancer: Change of pace and change of direction.  J Gastroenterol Hepatol2002; 17:17-2
  5. Sasaki O, Atkin WS, Jass JR. Mucinous carcinoma of the rectum. Histopathology 1987;11:259–272 .
  6. Benedix F,Kube R,Meyer F et al.Comparison of 17641 patients with right and left sided colon cancer:differences in epidemiology,perioperative course,histology and survival.Dis colon rectum.2010;53(1):57-64
  7. Bernini A, Spencer MP, Wong WD, et al: Computed tomography-guided percutaneous abscess drainage in intestinal disease. Factors associated with outcome. Dis Colon Rectum 40:1009, 1997.
  8. Hollerbach S,Geissler a etal. The accuracy of abdominal ultrasound in the assessment of bowel disorders. Scand J Gastreoenterol. 1998;33:1201-1208.
  9. Zaloudik J,Vagunda V,drahoupilova.M, et al:Biomarkers for predicting response to regional chemo- immunotherapy in liver metastases from colorectal carcinoma.Int J Immunopathol 19:481-485
  10. Qui H, Sirivongs P, Rothenberger M, et al: Molecular prognostic factors in rectal cancer treated by radiation and surgery. Dis Colon Rectum 43:451, 2000.

Corresponding Author

Dr Annu Sajeev

8B, AG-1, Vikaspuri, New Delhi 110018

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile: 9496370593